Amryt Pharma Archives -

Amryt Pharma has been handed a major blow by the FDA, after the US regulator rejected its marketing

FDA turns down Amryt’s epidermolysis bullosa drug

https://pharmaphorum.com/news/fda-turns-down-amryts-epidermolysis-bullosa-drug/

Rare disease specialist Amryt Pharma plans to expand its rare disease portfolio with the acquisition of troubled Aegerion

Amryt to expand rare disease portfolio with $311m Aegerion merger

https://pharmaphorum.com/news/amryt-to-expand-rare-disease-portfolio-with-311m-aegerion-merger/

Amryt looking to expand rare disease franchise

https://pharmaphorum.com/news/amryt-looking-expand-rare-disease-franchise/

Amryt Pharma